Resources

PDF | 2.02 MB

Predictive Biomarkers of Immunotherapy Toxicity in Metastatic Melanoma Patients

Immune checkpoint inhibitors (ICI), anti-CTLA-4 and anti-PD-1, have improved the overall survival and response rate in patients with metastatic melanoma1....